[Studies on the endocrinological metabolism of the parathyroid. I. The production of renal calcinosis by cyclic AMP injection in rat].
We found that a few patients with urolithiasis had normal parathyroid hormone levels but high cyclic AMP excretion. The purpose of this paper was to study the endocrinological mechanism. Male rats were given intraperitoneally dibutyryl cyclic AMP (DBcAMP), a derivative of cyclic AMP, per 100 gm of body weight for 50 days. Feed and water were supplied ad libitum. Crystal formation or calcification in mainly the dystal tubules and collecting system were found in 3 out of 10 rats, and renal calcium stones in 2 rats. The cyclic AMP of the renal parenchyma, especially the renal medulla, was elevated by more than 100 times after DBcAMP administration. Serum calcium levels, urinary calcium and phosphate excretion, and the adrenaline levels of the renal parenchyma were significantly increased. Serum parathyroid hormone was slightly enhanced, but vitamin D and the noradrenaline levels of the renal parenchyma were not changed. Based on these findings, it is suspected that stone formation in rats injected DBcAMP occurs through the action of DBcAMP on the renal tubules to increase urinary calcium excretion and to make renal stones as a form of primary hyperparathyroidism.
D000818:Animals; D003994:Bucladesine / Q000008:administration & dosage; D002118:Calcium / Q000097:blood; D000242:Cyclic AMP / Q000378:metabolism*; D006801:Humans; D006961:Hyperparathyroidism / Q000378:metabolism; D007267:Injections; D007668:Kidney / Q000378:metabolism; D007669:Kidney Calculi / Q000139:chemically induced / Q000378:metabolism*; D008297:Male; D010281:Parathyroid Hormone / Q000378:metabolism*; D010710:Phosphates / Q000097:blood; D051381:Rats; D011919:Rats, Inbred Strains
D010281:Parathyroid Hormone; D010710:Phosphates; D003994:Bucladesine; D000242:Cyclic AMP; D002118:Calcium